Exicure falls on stock offering plans

Exicure

19/12/2019 12:00

** Exicure Inc  XCUR.O  shares down 4.7% to $2.82 premarket
as co looks to price follow-on before the bell
    ** XCUR on track to fall for 5th straight session, if losses
hold
    ** Co late Weds announced proposed stock offering to further
develop its cancer and neurological drugs; offering size not
disclosed  urn:newsml:reuters.com:*:nBw4ZFV8da
    ** Sources say sole bookrunner Guggenheim marketing a $25
mln deal
    ** XCUR has 75.9 mln shares outstanding and 55.9 mln shares
of free float, per Refinitiv data
    ** Avg rating among 4 analysts is "strong buy"; median PT is
$8.50 (Refinitiv data)
    ** Stock has fallen 16.4% YTD

 ((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 646-223-5017))